Brand-name vs compounded
Hers vs JoinFridays: Brand-Name or Compounded? (2026)
Compare Hers and JoinFridays on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.8 and 9.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Two platforms, one drug class, and a difference in annual cost most people do not notice until month four. That is the Hers versus JoinFridays question.
The dividing line is regulatory, not cosmetic: Hers works with product the FDA has reviewed and approved, while JoinFridays runs on compounded medication prepared by a pharmacy rather than manufactured under an approved application. Everything else about the two — price, support, shipping — follows from that decision.
This comparison works from what each provider publishes: the entry price, what it becomes at month two, the medication actually dispensed, and what is bundled rather than billed. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest 12-month cost
- Hers — $1,788 against $1,800 at JoinFridays, on each provider's own best published pricing.
- FDA-approved medication
- Hers — FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- JoinFridays — Tirzepatide at $249/mo; the other side publishes semaglutide only.
- Most support included
- Hers — Personalized care team with ongoing dose check-ins.
Side-by-side comparison
Nothing in this table is our estimate. Where a provider does not publish something, the cell says so.
| Hers | JoinFridays | |
|---|---|---|
| Advertised price | Wegovy pill from $149/mo, injectable from $199/mo | From $117/mo |
| Rate after promotions | $149/mo | $249/mo |
| Pricing structure | Published rate per medication | Cheaper per month the longer you commit |
| Medication | FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Published upfront | Partly published |
| State coverage | Not published | Not published |
| How fast you start | Online intake with clinician review | Online intake |
| Membership fee | None | None |
| Patient reviews | 6,200 | 6,985 |
| eRxDoctor score | 9.8/10 | 9.0/10 |
What Hers and JoinFridays actually cost over a year
The advertised rate answers the wrong question. So the table works in the timeframe treatment actually happens in.
| Hers | JoinFridays | |
|---|---|---|
| First month | $149 | $117 |
| Months 2 onward | $149/mo | $249/mo |
| 6-month total | $894 | $1,362 |
| 12-month total | $1,788 | $2,856 |
| Best published plan | No multi-month discount published | 12-month plan at $1,800 — $1,800/yr |
Over a year that is a $12 difference, in Hers's favor. Whether it is the right call depends on whether JoinFridays gives you $1 a month of something you will use.
Price escalation to plan for: JoinFridays moves from $117 to $249, a 113% increase. Set a calendar reminder for the month it changes.
What is actually in the vial
Hers dispenses FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen: an approved finished drug, meaning the agency has reviewed both the evidence behind it and the facility that makes it.
JoinFridays supplies compounded semaglutide and compounded tirzepatide — compounded medication prepared by a pharmacy rather than manufactured under an approved application. That is what makes $249/mo possible in the first place, and it is also why the oversight is not the same.
Neither choice is wrong, but they are different risks. Paying $149/mo buys regulatory certainty. Paying less buys access, on terms where the manufacturing oversight is not the same.
Hers in detail
Hers offers FDA-approved Wegovy® (brand-name semaglutide) with a personalized care team and ongoing dose check-ins, no compounded medications. Against JoinFridays, that puts it in the position of the cheaper option.
Intake is online intake with clinician review. Fulfillment is home delivery, no insurance required. The commercial terms are published rate per medication, published upfront.
Behind the prescription sits personalized care team with ongoing dose check-ins. Available medication: FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen.
Hers pros
- Personalized care team with ongoing dose check-ins
- FDA-approved brand-name Wegovy®, not a compounded product
- No insurance required
Hers cons
- Higher starting price than most compounded competitors
- No compounded/generic alternative offered
The cost of choosing this over JoinFridays: there is no compounded tier to fall back on if the brand-name price stops working for you.
How JoinFridays works
JoinFridays provides compounded GLP-1 weight loss options starting at $117/month, no long-term contracts, personalized clinician guidance, and active promo codes. What it is really selling here is the term structure rewards commitment, with a 12-month plan that averages $150 a month.
Practically: online intake, home delivery, and a pricing model that is cheaper per month the longer you commit.
On the clinical side, personalized, clinician-guided care rather than a templated protocol, prescribing compounded semaglutide and compounded tirzepatide.
JoinFridays pros
- Lowest starting price in its tier at $117/month
- Both compounded tirzepatide and semaglutide available on one platform
- No membership fees, cancel anytime with no long-term contract
- Aggressive promo codes: up to $500 off tirzepatide (NEWYOU12) and up to $400 off semaglutide (NYNY12)
JoinFridays cons
- Promo code discounts are subject to change and may not always be available
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Lowest tier ($117) reflects introductory or shortest-term pricing; monthly plan is $249
Against Hers specifically, the trade you are making: the $117 headline is the shortest-term rate; the month-to-month plan is $249.
Hers or JoinFridays: matching the program to the patient
Choose Hers if:
- you want the full price in front of you before completing an intake
- you want an FDA-approved finished medication rather than a compounded preparation
- the monthly rate is the constraint — $149/mo against $249/mo
- delivery works the way you want it to: home delivery, no insurance required
Choose JoinFridays if:
- delivery works the way you want it to: home delivery
- you want to start on their timeline: online intake
- the level of clinical contact suits you: personalized, clinician-guided care rather than a templated protocol
- what it leads on is worth paying for in your case: the term structure rewards commitment, with a 12-month plan that averages $150 a month
What each one gives up
On price. $149/mo against $249/mo. JoinFridays is asking you to pay for the term structure rewards commitment, with a 12-month plan that averages $150 a month; decide whether that is a line item you will use.
On predictability. The pricing structures differ (published rate per medication versus cheaper per month the longer you commit), and structure, not headline rate, determines the twelve-month bill.
On access. Hers advertises online intake with clinician review and home delivery, no insurance required; JoinFridays advertises online intake and home delivery. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On medication. Hers covers FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen; JoinFridays covers compounded semaglutide and compounded tirzepatide. Only JoinFridays publishes a tirzepatide route, which matters if semaglutide underdelivers.
The medication, not the platform
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
The FDA is explicit that a compounded preparation has not been reviewed for safety, effectiveness or manufacturing quality the way an approved drug has, per FDA.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
Hers vs JoinFridays: common questions
Which costs less over a year, Hers or JoinFridays?
Hers, at roughly $1,788 for twelve months against $1,800 at JoinFridays, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Hers cheaper than JoinFridays?
Yes, on the ongoing rate. Hers runs $149/mo once promotional pricing ends, against $249/mo at JoinFridays — a difference of 67%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Is Hers or JoinFridays better for a first GLP-1 prescription?
For a first prescription, weight support over price. Hers offers more contact (personalized care team with ongoing dose check-ins), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
Can I switch from Hers to JoinFridays later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
Are Hers and JoinFridays legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Hers operates on published rate per medication with pricing published upfront, JoinFridays on cheaper per month the longer you commit, partly published. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
The verdict
On the numbers, Hers wins the year: $1,788 against $1,800. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where JoinFridays justifies itself is the term structure rewards commitment, with a 12-month plan that averages $150 a month. Where it does not is anywhere the extra spend buys features you will never open.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- Shed vs HersPublished price vs quote-only
- Hers vs TrimRxBrand-name vs compounded
- JoinFridays vs TMatesTirzepatide access
- JoinFridays vs Elevate HealthBudget vs premium
- Enhance MD vs Ro.coBrand-name vs compounded
- Directmeds vs Ro.coBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Hers or JoinFridays, and does not sell treatment. Read our ranking methodology.